Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | $1,810.1M | $1,979.6M | $2,662.7M | $2,953.0M | ($2,071.9M) | $4,328.8M | $5,069.5M | $4,347.7M | $4,088.6M | $4,684.8M | $2,390.5M | $2,408.4M | $2,737.6M | ($204.1M) | $3,232.0M | $4,637.9M | $6,193.7M | $5,581.7M | $6,244.8M | $5,240.4M |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Eli Lilly and Company's last 12-month Net Income is $8,369.9M, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Eli Lilly and Company's Net Income growth was 67.8%. The average annual Net Income growth rates for Eli Lilly and Company have been 11.2% over the past three years, 1.0% over the past five years.
Over the last year, Eli Lilly and Company's Net Income growth was 67.8%, which is higher than industry growth of (0.3%). It indicates that Eli Lilly and Company's Net Income growth is Good.